Albemarle Stock Fair Value Trimmed as Analysts Turn Cautious
Albemarle Corp's modeled fair value dropped to $168.56 amid cautious analyst sentiment, balancing resilient lithium demand against pricing pressures and higher discount rates.
Albemarle Corp's modeled fair value dropped to $168.56 amid cautious analyst sentiment, balancing resilient lithium demand against pricing pressures and higher discount rates.
Argus Research lowered its price target for Eastman Chemical Company (EMN) to $62.00, while the current trading price stands at $64.11.
Albemarle's fair value estimate dropped 7.8% to US$172.56 following revised lithium pricing assumptions. Analysts remain divided between cost efficiency benefits and concerns over lower lithium prices
Dow Inc. partnered with Xylem to deploy advanced water systems at its Fort Saskatchewan facility. This initiative supports Path2Zero goals by reducing freshwater demand and improving efficiency by Aug
Dow Inc. shares rose 39.1% in six months due to cost-saving initiatives and advantaged feedstock positions. Analysts have revised earnings estimates upward for 2026, highlighting undervaluation and st
Financial analysts compare Dow Inc. and Albemarle Corp, identifying Dow as the superior value option based on valuation metrics despite both holding Strong Buy Zacks Ranks.